"Clinically I cannot wait to see what combination therapy with SGLT2 inhibitors and/or Kerendia will demonstrate." A randomized, double-blind, parallel-group, placebo-controlled, superiority trial comparing injectable semaglutide 1.0 mg with placebo as an adjunct to standard of care for people with type 2 diabetes and CKD, FLOW enrolled 3533 people from more than 2 dozen countries
This helps maintain consistent dosing and efficacy
Water, herbal tea, and unsweetened beverages remain the safest long-term choices
These medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
The term has emerged in informal community discussion as a shorthand for "the third generation of GLP-class peptides" specifically retatrutide, which acts on three receptors (GLP-1, GIP, and glucagon)